lobbying_activities: 1877724
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1877724 | a363ba9b-d5e4-4095-97c4-bdea951394de | Q3 | FAEGRE BAKER DANIELS CONSULTING | 34158 | MYRIAD GENETIC LABORATORIES, INC. | 2016 | third_quarter | MED | FDA draft guidance to regulate laboratory developed tests and companion diagnostics. Legislation to further regulate clinical labs under CLIA and FDA. | HOUSE OF REPRESENTATIVES,SENATE | 15000 | 0 | 0 | 2016-10-14T14:27:49.813000-04:00 |